fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm]
fluorometholone
RxCUI: 208420
What the CMS Formulary Data Shows for fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm]
Per the CMS 2026 Part D formulary file, fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm] (RxNorm concept RXCUI 208420, generic name fluorometholone) appears on 17 distinct formulary files spanning 250 Medicare Part D plan offerings - 4.9% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.2.
Real-world access to fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 168,211 Part D beneficiaries filled fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm] in 2023, with total plan-and-beneficiary spending of $28,583,158 and an average per-beneficiary annual cost of $169.92. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm] today.
Coverage Details
- Formularies covering
- 17
- Plans covering
- 250
- Coverage rate
- 4.9%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 168,211
- Total spending
- $28,583,158
- Avg per beneficiary
- $169.92
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm] covered by Medicare Part D?
Yes, fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm] is covered by 250 Medicare Part D plans (4.9% of all Part D formularies).
What tier is fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm] on Medicare Part D plans?
fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm] averages Tier 3.2 across Part D plans, ranging from Tier 1 to Tier 4.
Does fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm] require prior authorization?
0% of Part D formularies require prior authorization for fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm]?
In 2023, total Medicare Part D spending on fluorometholone 2.5 MG/ML Ophthalmic Suspension [FML Forte Liquifilm] was $28,583,158, covering 168,211 beneficiaries. The average spend per beneficiary was $169.92.
Read our methodology - how this data is sourced, computed, and verified.